Page last updated: 2024-10-27

fluoxetine and Communicable Diseases

fluoxetine has been researched along with Communicable Diseases in 2 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Communicable Diseases: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Peters, JU1
Aulsebrook, LC1
Wong, BBM1
Hall, MD1

Reviews

1 review available for fluoxetine and Communicable Diseases

ArticleYear
Polypharmacology - foe or friend?
    Journal of medicinal chemistry, 2013, Nov-27, Volume: 56, Issue:22

    Topics: Animals; Communicable Diseases; Drug Evaluation, Preclinical; Drug Repositioning; Humans; Polypharma

2013

Other Studies

1 other study available for fluoxetine and Communicable Diseases

ArticleYear
Can pharmaceutical pollution alter the spread of infectious disease? A case study using fluoxetine.
    Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2023, 03-27, Volume: 378, Issue:1873

    Topics: Animals; Communicable Diseases; Ecosystem; Fluoxetine; Host-Pathogen Interactions; Humans; Pharmaceu

2023